Lycia Therapeutics, Inc.
4 additional officers and directors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- $75Msold on Form D
Filed a Form D on 10 Jun 2026: $75M sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.
A company that just raised has fresh capital, a new board and new vendors to choose.
- 2 investorsnamed
2 investors on record.
The investors already on the cap table shape who leads the next round.
- 7 directorsboard
7 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Facts
Financing history
- Jun 10, 2026Form D equity offering · $75.0M (form d sold) · 16 investorsFact Form D · “Lycia Therapeutics, Inc. filed Form D: $75,000,000 sold of $75,000,000, Biotechnology”
- Apr 26, 2024Form D equity offering · $107M (form d sold) · 16 investorsFact Form D · “Lycia Therapeutics, Inc. filed Form D: $106,600,004 sold of $106,600,004, Biotechnology”
Investors on record
- Inspired Capital Partners, LLC board only, Ming Fang (strongly supported) Inference sec.gov
- Versant Venture Management, LLC board only, Clare Ozawa (strongly supported) Inference sec.gov
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.No firm portfolio page lists this company, so no outcome is stated.
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.People
- Aetna Wun Trombley Executive Officer/Director sec.gov
- AMY Bachrodt Executive Officer sec.gov
- Ming Fang Director Inference
- TIM Anderson Director Fact
- William Rieflin Director Fact
Timeline
Evidence
Every observation on this company
- Entity type: Corporation Jun 25, 2026 Fact Form D
- Entity type: Corporation May 23, 2024 Fact Form D
- Form D industry group: Biotechnology Jun 25, 2026 Fact Form D
- Form D industry group: Biotechnology May 23, 2024 Fact Form D
- Amendment: false Jun 25, 2026 Fact Form D
- Amendment: false May 23, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Jun 25, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose May 23, 2024 Fact Form D
- Incorporated: overFiveYears Jun 25, 2026 Fact Form D
- Incorporated: withinFiveYears May 23, 2024 Fact Form D
- Jurisdiction: Delaware Jun 25, 2026 Fact Form D
- Jurisdiction: Delaware May 23, 2024 Fact Form D
- Amount sold (Form D): $75.0M Jun 25, 2026 Fact Form D
- Amount sold (Form D): $107M May 23, 2024 Fact Form D
- Offering amount (Form D): $75.0M Jun 25, 2026 Fact Form D
- Offering amount (Form D): $107M May 23, 2024 Fact Form D
- Exemptions: 06b Jun 25, 2026 Fact Form D
- Exemptions: 06b May 23, 2024 Fact Form D
- First sale: 2026-06-10 Jun 25, 2026 Fact Form D
- First sale: 2024-04-26 May 23, 2024 Fact Form D
- Investors (Form D): 16 Jun 25, 2026 Fact Form D
- Investors (Form D): 16 May 23, 2024 Fact Form D
- Minimum investment (Form D): 0 Jun 25, 2026 Fact Form D
- Minimum investment (Form D): 0 May 23, 2024 Fact Form D
- Securities offered: equity Jun 25, 2026 Fact Form D
- Securities offered: equity May 23, 2024 Fact Form D
- Office address: Jun 25, 2026 Fact Form D
- Office address: May 23, 2024 Fact Form D
- Year of incorporation: 2019 May 23, 2024 Fact Form D
Relationships across DFX
2 capital paths
Lycia Therapeutics, Inc. sits on 2 traced paths of capital across the graphs.
DFX traced 2 paths of capital through this record
Every record on each path, what it committed or lent, and as of when.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.
Checking your plan…
Record history
- Form D filed2026-06-25source on record
- Form D filed2024-05-23source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.